Delivery Order SPE2DB20D1100-SPE2DB25FD9N8
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,126.05 to AmerisourceBergen Drug Corp for Doxorubicin Liposome 50mg/25ml on July 31, 2025, with completion scheduled for August 1, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a continuation of AmerisourceBergen's established relationship with the federal government as a critical pharmaceutical distributor. The order is being fulfilled from the vendor's location in...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $5,400.00 fixed-price delivery order is for the supply of 4,564,081,943 units of Doxorubicin Liposome 20mg/10ml 10ml, a specialty pharmaceutical product, with a performance period through March 27, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxorubicin 200 mg/100 mL vials totaling $1,928.51 with a firm fixed price arrangement. The contract, which is non-set-aside and competitively awarded, was finalized on July 22, 2025, with an ultimate completion date of July 23, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,252.65 on June 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price delivery order, which is not set-aside and was competitively awarded, has an ultimate completion date of June 20, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,697.48 by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract represents a child award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the awardee's...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $1,542.24 to AmerisourceBergen Drug Corp on August 20, 2025, with an ultimate completion date of August 21, 2025. This contract is classified as a child award under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order utilizes firm fixed-price pricing and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $91,548.12 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025. This firm fixed-price, non-set-aside contract is classified as a child award, indicating it derives from a larger indefinite delivery contract vehicle. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 4, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $56,353.65 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. The contract, designated as a child order under a larger indefinite delivery contract vehicle, carries a firm fixed price structure with an ultimate completion date of August 19, 2025. This award was competitively procured with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,454.56 by the Defense Logistics Agency's Medical Supply Chain on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The company, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...